News
The FDA announced that it has approved patisiran infusion for the treatment of patients with peripheral nerve disease caused by hereditary transthyretin-mediated…
A UCL-led study has confirmed that some vials of a hormone used in discontinued medical treatments contained seeds of a protein implicated in Alzheimer's disease,…
Tiny protein structures called amyloids are key to understanding certain devastating age-related diseases. Aggregates, or sticky clumped-up amyloids, form plaques…
Toxic protein assemblies, or "amyloids," long considered being key drivers in many neuromuscular diseases, also playing a beneficial role in the development of…
Rare Disease Day takes place on the last day of February each year. The main objective of Rare Disease Day is to raise awareness amongst the general public and…
Due to the global COVID-19 (Coronavirus) pandemic, the American Academy of Neurology has no choice but to make the necessary decision to cancel the AAN's Annual…
Pfizer Inc. announced today that the US Food and Drug Administration (FDA) accepted for filing the company's New Drug Applications (NDAs) for tafamidis for the…
Eidos Therapeutics, Inc., today announced the initiation and design of its pivotal global Phase 3 trial (ATTRibute-CM) of AG10 in patients with Transthyretin (TTR)…
Join Sean McDonough for this special two-day event to benefit cardiac amyloidosis research at Brigham and Women's Hospital.
* Sunday, August 6, 2023: Sam Adams…
The annual Corvettes for Chip Show will be held in conjunction with the Carlisle GM Nationals for 2022! Corvettes for Chip will operate as a "Show within a Show" at…